Cerus (FRA:CU2) Days Payable : 138.57 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Cerus Days Payable?

Cerus's average Accounts Payable for the three months ended in Dec. 2023 was €29.0 Mil. Cerus's Cost of Goods Sold for the three months ended in Dec. 2023 was €19.1 Mil. Hence, Cerus's Days Payable for the three months ended in Dec. 2023 was 138.57.

The historical rank and industry rank for Cerus's Days Payable or its related term are showing as below:

FRA:CU2' s Days Payable Range Over the Past 10 Years
Min: 117.44 Med: 162.75 Max: 222.7
Current: 176.63

During the past 13 years, Cerus's highest Days Payable was 222.70. The lowest was 117.44. And the median was 162.75.

FRA:CU2's Days Payable is ranked better than
81.78% of 785 companies
in the Medical Devices & Instruments industry
Industry Median: 73.19 vs FRA:CU2: 176.63

Cerus's Days Payable declined from Dec. 2022 (151.87) to Dec. 2023 (138.57). It may suggest that Cerus accelerated paying its suppliers.

Cerus Days Payable Historical Data

The historical data trend for Cerus's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cerus Days Payable Chart

Cerus Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

220.33

215.08

167.04

161.64

150.80

Cerus Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															151.87	232.64	193.70	191.72	138.57

Competitive Comparison of Cerus's Days Payable

For the Medical Devices subindustry, Cerus's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cerus's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cerus's Days Payable distribution charts can be found below:

* The bar in red indicates where Cerus's Days Payable falls into.

Cerus Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cerus's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (31.154	+	21.863)	/	2 )	/	64.16	*	365
=	26.5085					/	64.16	*	365
=	150.80

Cerus's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (36.092	+	21.863)	/	2 )	/	19.082	*	365 / 4
=	28.9775					/	19.082	*	365 / 4
=	138.57

Cerus Days Payable Related Terms

Thank you for viewing the detailed overview of Cerus's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cerus (FRA:CU2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cerus Corp (FRA:CU2) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CERS:USA CU2:Germany

Address

1220 Concord Avenue, Suite 600, Concord, CA, USA, 94520

Website

http://www.cerus.com

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Cerus (FRA:CU2) Headlines

No Headlines